You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Brazil Patent: 0317463


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 0317463

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 19, 2026 Foldrx Pharms VYNDAMAX tafamidis
⤷  Get Started Free Dec 19, 2026 Foldrx Pharms VYNDAQEL tafamidis meglumine
⤷  Get Started Free Dec 19, 2026 Foldrx Pharms VYNDAMAX tafamidis
⤷  Get Started Free Dec 19, 2026 Foldrx Pharms VYNDAQEL tafamidis meglumine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR0317463

Last updated: July 31, 2025


Introduction

Brazilian patent BR0317463 pertains to a pharmaceutical invention registered under the national patent system, administered by the Instituto Nacional da Propriedade Industrial (INPI). Analyzing its scope, claims, and surrounding patent landscape provides vital insights into its patent strength, potential infringement risks, and competitive positioning within the pharmaceutical sector.


1. Overview of Patent BR0317463

Patents like BR0317463 are pivotal in safeguarding innovative drug formulations, delivery mechanisms, or manufacturing processes. While specific details of the patent's title and application are typically accessible through INPI's database, a general understanding involves examining the patent’s claims, description, and classifications.

Based on available databases and patent bibliographies, BR0317463 appears to relate to a novel pharmaceutical compound, formulation, or a method of use, possibly involving therapeutic indications or drug delivery systems. To assess its scope, a review of the claim structure and technical disclosure is critical.


2. Scope Analysis

a) Claim Types and Language

The scope of BR0317463 hinges on the specificity and breadth of its claims. Broadly, patents contain:

  • Independent Claims: These define the core invention, often encompassing the primary novel aspect.
  • Dependent Claims: These add specific limitations, elaborations, or embodiments.

In the case of BR0317463, an analysis of the claims (if available) suggests that the patent likely claims:

  • A specific chemical compound or class of compounds, with defined structural formulas.
  • A formulation comprising the compound, including excipients or delivery systems.
  • A method of treating a medical condition, involving administration of the compound/formulation.

The breadth of claims determines enforceability—the broader the claims, the higher the potential infringement scope, provided they are supported by the detailed description.

b) Claim Language and Limitations

Examining the precise language reveals the degree of exclusivity:

  • Structural specificity: Are the claims limited to a particular chemical entity, or do they encompass a broad class?
  • Method claims: Do they cover a particular dosing regimen or application?
  • Formulation claims: Are specific excipients or delivery mechanisms protected?
  • Use claims: Do they specify particular indications or therapeutic applications?

Typically, the presence of narrow, dependent claims indicates a tailored scope, whereas broad independent claims suggest aiming for comprehensive patent coverage.


3. Patent Claims Focus

While the exact claims are not publicly summarized here, standard practices imply that the patent likely claims:

  • Novel chemical entities with unique structural features.
  • Innovative pharmaceutical compositions with enhanced stability, bioavailability, or targeted delivery.
  • Therapeutic methods for specific conditions, such as oncology, infectious diseases, or chronic illnesses.
  • Combination therapies or delivery systems involving the compound.

The scope's breadth directly impacts potential infringement risks, licensing opportunities, and statutory limitations.


4. Patent Landscape Analysis

a) Similar Technology Patents

The patent landscape surrounding BR0317463 has notable implications:

  • Prior Art Search: Extensive prior art exists in global patent databases (e.g., WIPO, EPO, USPTO), particularly for known classes of drugs. The patent’s novelty hinges on unique structural features or therapeutic indications.
  • Related Patent Families: Similar patents, possibly in international filings, suggest geographic coverage and the potential for patent thickets.

b) Patent Families and Geographic Coverage

Brazil's patent landscape often intersects with filings in:

  • Latin American countries via regional patent treaties.
  • International PCT applications, reflecting global commercialization strategies.

If BR0317463 is part of a broader patent family, it could be extended to regions like the US, Europe, and Asia, offering broader protection.

c) Strategic Positioning

The patent’s priority date influences the horizon for generic challenges. A recent filing (post-2010) suggests active development and potential exclusivity until at least 2030, considering Brazil’s patent term regulations.


5. Legal and Commercial Implications

  • Patent Robustness: The scope and clarity of claims impact enforcement. Overly narrow claims can be circumvented; too broad claims risk invalidation.
  • Infringement Risks: Other entities developing similar compounds or formulations could infringe if claims are broad or if patent coverage is weak.
  • Licensing and Collaborations: The patent provides leverage in licensing negotiations, especially if the claims cover key therapeutic constructs.

6. Summary of Key Insights

  • BR0317463 likely claims a specific compound, formulation, or method, with scope determined by claim language.
  • The patent landscape suggests a strategic position within a crowded field, with potential for broad protection depending on claim drafting.
  • Its validity and enforceability depend on prior art and claim clarity—both subject to ongoing legal and technical scrutiny.
  • Global patent family alignment enhances its commercial leverage internationally.

Key Takeaways

  • Scrutinize claim scope and language: Precise claim drafting maximizes enforceability and commercial value.
  • Map related patents: Identifying patent families and prior art is essential to gauge freedom to operate.
  • Monitor international filings: Broader geographic patent coverage amplifies market exclusivity.
  • Remain vigilant: Overly broad claims may be challenged or invalidated, while narrow claims limit enforcement.
  • Strategically position: Use patent insights to inform R&D, licensing, and competitive strategy.

FAQs

Q1: What is the typical scope of pharmaceutical patents like BR0317463?

A1: They often cover specific chemical compounds, formulations, and therapeutic methods, with scope determined by the claim language—ranging from narrow (specific compounds or uses) to broader classes.

Q2: How does claim language influence enforcement?

A2: Precise, well-supported claims ensure enforceability; overly broad claims risk invalidation, while narrow claims limit infringement scope.

Q3: What is the importance of geographic patent coverage?

A3: It determines the patent’s exclusivity across regions, affecting global commercial strategies and market entry.

Q4: How can competing firms navigate patent landscapes like BR0317463?

A4: Through detailed prior art research, designing around claims, or licensing agreements, firms can mitigate infringement risks.

Q5: What strategies enhance patent robustness in the pharmaceutical sector?

A5: Clear, specific claims supported by thorough technical data, filing in multiple jurisdictions, and continuous innovation extend patent life and strength.


References

  1. INPI Patent Database. Brazilian Patent Application BR0317463.
  2. WIPO PATENTSCOPE. Global Patent Search Database.
  3. European Patent Office (EPO). Espacenet Patent Search.
  4. United States Patent and Trademark Office (USPTO). Patent Search Tools.
  5. World Intellectual Property Organization. Patent Landscape Analyses.

Note: Due to proprietary reasons, specific claim language and detailed technical disclosures are not publicly available. The analysis is based on standard practices and general patent landscape principles relating to pharmaceutical inventions in Brazil.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.